[1] |
中国抗癌协会泌尿男生殖系肿瘤专业委员会前列腺癌学组. 前列腺癌筛查中国专家共识(2021年版)[J]. 中国癌症杂志, 2021, 31(5): 435-440.
|
|
Prostate Cancer Group, Urogenital Tumor Professional Committee, Chinese Anti-Cancer Association. Chinese expert consensus on prostate cancer screening (2021 version)[J]. China Oncol, 2021, 31(5): 435-440.
|
[2] |
李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
|
|
LI X, ZENG X Y. Advances in epidemiology of prostate cancer in China[J]. Cancer Res Prev Treat, 2021, 48(1): 98-102.
|
[3] |
CAI T, SANTI R, TAMANINI I, et al. Current knowledge of the potential links between inflammation and prostate cancer[J]. Int J Mol Sci, 2019, 20(15): E3833.
|
[4] |
ZHANG L, WANG Y, QIN Z Q, et al. Correlation between prostatitis, benign prostatic hyperplasia and prostate cancer: a systematic review and meta-analysis[J]. J Cancer, 2020, 11(1): 177-189.
doi: 10.7150/jca.37235
|
[5] |
PERLETTI G, MONTI E, MAGRI V, et al. The association between prostatitis and prostate cancer. Systematic review and meta-analysis[J]. Arch Ital Urol Androl, 2017, 89(4): 259-265.
doi: 10.4081/aiua.2017.4.259
|
[6] |
DOAT S, MAROUS M, REBILLARD X, et al. Prostatitis, other genitourinary infections and prostate cancer risk: influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study[J]. Int J Cancer, 2018, 143(7): 1644-1651.
doi: 10.1002/ijc.31565
|
[7] |
米志静. Nemo样激酶与肿瘤相关性疾病研究进展[J]. 安徽医药, 2016, 20(11): 2024-2027.
|
|
MI Z J. Research progress of nemo-like kinase (NLK)and cancer-related diseases[J]. Anhui Med Pharm J, 2016, 20(11): 2024-2027.
|
[8] |
HUANG Y, YANG Y, HE Y, et al. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers[J]. Tumour Biol, 2015, 36(12): 9147-9152.
doi: 10.1007/s13277-015-4159-7
|
[9] |
WANG J, YANG Z H, CHEN H, et al. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer[J]. BMC Cancer, 2016, 16: 257.
doi: 10.1186/s12885-016-2291-4
|
[10] |
STAAL J, BEYAERT R. Inflammation and NF-κB signaling in prostate cancer: mechanisms and clinical implications[J]. Cells, 2018, 7(9): E122.
|
[11] |
CHEN Y Z, XIN H H, PENG H, et al. Hypomethylation-linked activation of PLCE1 impedes autophagy and promotes tumorigenesis through MDM2-mediated ubiquitination and destabilization of p53[J]. Cancer Res, 2020, 80(11): 2175-2189.
|
[12] |
ZHU D L, ZHENG S, FANG C, et al. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p[J]. Cancer Lett, 2020, 477: 107-121.
doi: 10.1016/j.canlet.2020.02.033
|
[13] |
ZHANG H H, LI S Z, ZHANG Z Y, et al. Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage[J]. Cell Death Differ, 2014, 21(10): 1656-1663.
doi: 10.1038/cdd.2014.78
|
[14] |
王建, 陈华, 丁聪聪. 微管相关蛋白Nur77在前列腺癌转移中的作用及其机制的探讨[J]. 肿瘤, 2018, 38(2): 111-119.
|
|
WANG J, CHEN H, DING C C. The role of microtubule regulatory protein Nur77 in metastasis of prostate cancer and its mechanism[J]. Tumor, 2018, 38(2): 111-119.
|
[15] |
FANG L Y, IZUMI K, LAI K P, et al. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling[J]. Cancer Res, 2013, 73(18): 5633-5646.
|
[16] |
LI S Z, ZHANG H H, LIANG J B, et al. Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKβ[J]. Biochim Biophys Acta, 2014, 1843(7): 1365-1372.
|
[17] |
SONG L, MARTINEZ L, ZIGMOND Z M, et al. c-Kit modifies the inflammatory status of smooth muscle cells[J]. PeerJ, 2017, 5: e3418.
doi: 10.7717/peerj.3418
|
[18] |
BEARD J A, TENGA A, HILLS J, et al. The orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network[J]. Sci Rep, 2016, 6: 25108.
doi: 10.1038/srep25108
|
[19] |
CARRÀ G, LINGUA M F, MAFFEO B, et al. P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa[J]. Cell Mol Life Sci, 2020, 77(22): 4449-4458.
doi: 10.1007/s00018-020-03524-9
|
[20] |
LEE Y K, YI E Y, PARK S Y, et al. Mitochondrial dysfunction suppresses p53 expression via calcium-mediated nuclear factor-κB signaling in HCT116 human colorectal carcinoma cells[J]. BMB Rep, 2018, 51(6): 296-301.
doi: 10.5483/BMBRep.2018.51.6.232
|